← FDA Drug Approvals (Drugs@FDA)

LANSOPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA LTD · Approved 2012-12-18

Drug application

FDA Application #
ANDA201921
Application type
Abbreviated New Drug Application (Generic)
Brand name
LANSOPRAZOLE
Generic name
Lansoprazole
Active ingredients
LANSOPRAZOLE
Dosage form
CAPSULE, DELAYED REL PELLETS
Route
ORAL
Marketing status
Prescription
Sponsor
NATCO PHARMA LTD
First approval
2012-12-18

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown